- Home
- CCM vs BRNS Comparison
CCM vs BRNS Comparison
Compare CCM & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- BRNS
- Stock Information
- Founded
- CCM 1997
- BRNS 2016
- Country
- CCM China
- BRNS United Kingdom
- Employees
- CCM N/A
- BRNS 105
- Industry
- CCM Medical/Nursing Services
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- CCM Health Care
- BRNS Health Care
- Exchange
- CCM Nasdaq
- BRNS Nasdaq
- Market Cap
- CCM 33.3M
- BRNS 36.0M
- IPO Year
- CCM 2009
- BRNS 2021
- Fundamental
- Price
- CCM $5.62
- BRNS $0.95
- Analyst Decision
- CCM
- BRNS Strong Buy
- Analyst Count
- CCM 0
- BRNS 1
- Target Price
- CCM N/A
- BRNS $3.00
- AVG Volume (30 Days)
- CCM 3.2K
- BRNS 11.5K
- Earning Date
- CCM 04-25-2025
- BRNS 08-07-2025
- Dividend Yield
- CCM N/A
- BRNS N/A
- EPS Growth
- CCM N/A
- BRNS N/A
- EPS
- CCM N/A
- BRNS N/A
- Revenue
- CCM $52,603,198.00
- BRNS $14,969,000.00
- Revenue This Year
- CCM N/A
- BRNS N/A
- Revenue Next Year
- CCM N/A
- BRNS N/A
- P/E Ratio
- CCM N/A
- BRNS N/A
- Revenue Growth
- CCM N/A
- BRNS 4381.74
- 52 Week Low
- CCM $3.80
- BRNS $0.64
- 52 Week High
- CCM $10.90
- BRNS $1.58
- Technical
- Relative Strength Index (RSI)
- CCM 39.44
- BRNS 53.29
- Support Level
- CCM $4.91
- BRNS $0.90
- Resistance Level
- CCM $5.95
- BRNS $0.94
- Average True Range (ATR)
- CCM 0.25
- BRNS 0.05
- MACD
- CCM -0.05
- BRNS 0.00
- Stochastic Oscillator
- CCM 36.60
- BRNS 69.22
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.